Most digital health companies stall between product-market fit and scale. The clinical validation is there, but the go-to-market motion hasn't caught up. We embed growth operators who build the engine — channels, messaging, conversion — so your team can focus on the product.
The Problem
Clinical proof doesn't translate to commercial traction
You've validated the product with clinicians, payers, or patients — but pipeline isn't growing at the rate investors expect. The disconnect between clinical evidence and commercial messaging means your sales team is pitching outcomes that prospects don't understand or don't trust yet. This gap widens every quarter you don't close it, and competitors with weaker products but stronger GTM are winning deals.
Regulatory constraints limit your marketing playbook
Digital health companies can't run the same growth tactics as a typical SaaS company. HIPAA, FDA clearance language, and payer compliance requirements restrict what you can say, where you can say it, and how you can target. Most growth teams either ignore these constraints and create legal risk, or over-correct and produce messaging so cautious it says nothing at all.
Channel economics don't work at your price point
Enterprise digital health deals have long sales cycles and high CAC. If you're selling to health systems, your paid acquisition channels are burning cash without clear attribution. If you're D2C, your unit economics depend on retention curves that take months to materialize. Either way, the channel mix that got you to your first customers won't get you to your next hundred.
Your growth team is too small for the surface area
Most Series A and B digital health companies have one or two marketers trying to cover demand gen, content, product marketing, partnerships, and sales enablement simultaneously. Nobody is going deep on any channel. The result is a scattered effort that produces activity but not compounding growth.
How We Help
We start by auditing your current growth infrastructure — what channels are active, what's converting, where the funnel breaks, and how your messaging maps to buyer intent at each stage. In digital health, this means understanding not just your marketing metrics but your regulatory boundaries, reimbursement model, and clinical evidence package. The audit typically surfaces two or three high-leverage opportunities that are being underexploited.
From there, we build a growth strategy anchored to your specific commercial model. If you're selling to health systems, we design an account-based approach that maps clinical champions to economic buyers and builds the content and outreach sequences to move both. If you're D2C, we build the paid and organic acquisition funnels with proper cohort tracking so you can see true LTV:CAC before you scale spend.
Execution is where most consultants disappear. We don't. Our team embeds with yours — attending standups, building campaigns, writing copy, setting up attribution. We operate as a fractional growth team, not advisors who hand over a deck and leave. This means we're accountable to the same metrics your board cares about.
We instrument everything for measurement from day one. In digital health, attribution is harder because sales cycles are long and multi-touch. We build the tracking infrastructure to connect top-of-funnel activity to pipeline and closed revenue, even across 6-12 month cycles. This gives you — and your investors — a clear picture of what's working and what to double down on.
What makes Winston Francois different here is the operator mentality. We've worked with enough digital health companies to know the regulatory constraints, the payer dynamics, and the clinical validation requirements. We don't waste your first month learning your industry. We show up knowing it.
What we deliver
- Growth audit and channel opportunity map — identifying the 2-3 highest-leverage growth levers for your specific model
- Commercial messaging framework — translating clinical evidence into buyer-ready language that stays compliant
- Channel strategy and 90-day execution plan — with specific targets, budgets, and accountability metrics
- Attribution and measurement infrastructure — connecting marketing activity to pipeline and revenue
- Monthly growth reviews — with data-driven recommendations for reallocation and scaling
Most digital health companies have a messaging problem disguised as a growth problem. The clinical evidence exists, but it's trapped in white papers and conference decks instead of being translated into the language that economic buyers actually use to make purchasing decisions.
Our Methodology
Our methodology follows a 90-day sprint structure designed for the realities of digital health go-to-market. In the first 30 days, we run a full growth audit: channel performance, funnel conversion rates, messaging effectiveness, competitive positioning, and regulatory compliance review. We interview your sales team, review lost deals, and map the buyer journey from first touch to closed revenue.
Days 30-60 are strategy and infrastructure. We build the growth plan, set up tracking and attribution, create the messaging frameworks, and launch the first campaigns. Everything is designed to generate learnings fast — we'd rather run three focused experiments than one big campaign.
Days 60-90 are optimization and scaling. By this point, we have real data on what's working. We double down on winning channels, kill underperformers, and start building the repeatable playbook your team will own long-term. This is fundamentally different from traditional consulting because we're building and operating, not just advising. And it's different from agency work because we're embedded in your team, not running campaigns from the outside.
How We Work
In the first 30 days, we're in deep audit mode. Expect daily interaction with your growth and sales teams, access requests to your analytics and CRM, and a series of stakeholder interviews. We'll deliver a growth audit document and a prioritized roadmap by day 30.
From days 30-60, we shift to building. Our team works alongside yours — typically a fractional growth lead plus specialist support in the priority channels (paid, content, product marketing, or partnerships depending on the audit findings). We attend your team standups and report into your existing rhythms.
Days 60-90 are about proving the model. We're running campaigns, measuring results, and iterating weekly. By the end of the sprint, you'll have a clear picture of which channels work, what your true CAC is by segment, and a playbook for scaling. Most engagements run 3-6 months, with the first 90 days focused on building the engine and months 4-6 on scaling what works.
On the client side, we need a single point of contact with decision-making authority, access to your data and tools, and a willingness to move fast. We operate on weekly sprint cycles with monthly executive reviews.
- CAC reduction through channel mix optimization
- Pipeline velocity improvement
- Messaging-to-conversion rate improvement
- Attribution infrastructure buildout
If your digital health company needs growth strategy leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
How much does a growth strategy engagement cost for digital health companies?
Typical engagements range from $15K-$40K per month depending on scope and team size. That's significantly less than hiring a VP of Growth ($250K-$350K fully loaded) and more accountable than a traditional agency retainer. The exact cost depends on how many channels we're activating and whether you need strategic guidance only or embedded execution support.
How long before we see results from a growth strategy engagement?
You'll see initial data and insights within the first 30 days during the audit phase. Measurable improvements in lead volume and conversion rates typically appear by day 60-90. Pipeline impact — actual revenue influence — takes longer in digital health because of longer sales cycles, but we build the attribution to show progress indicators early. Most clients see clear ROI by month 4.
How does the growth strategy team integrate with our existing marketing staff?
We embed directly into your team's workflow. That means attending your standups, using your project management tools, and reporting into your existing cadence. We're not a separate team running campaigns in a black box. The fractional growth lead acts as a peer to your marketing director or VP, and specialist support plugs into specific channel gaps. Weekly syncs and monthly executive reviews keep everyone aligned.
What makes Winston Francois different from a traditional growth agency?
Two things: operator mentality and industry depth. We've worked with enough digital health companies to understand HIPAA constraints, payer dynamics, clinical validation requirements, and health system procurement cycles. We don't spend your first month learning your industry. And we operate as embedded team members accountable to your metrics, not as an outside agency optimizing for billable hours.
How do you measure ROI from a growth strategy engagement?
We measure what matters to your board: CAC by channel and segment, pipeline velocity, conversion rates at each funnel stage, and ultimately revenue influenced. We build the attribution infrastructure in the first 30 days so we can track these metrics accurately. Monthly growth reviews present the data clearly — what's working, what isn't, and where to reallocate resources.
What type of digital health company is the right fit for this service?
We work best with digital health companies between $5M and $100M in revenue that have validated their product but haven't built a repeatable growth engine yet. Series A through growth stage. You should have some existing traction — customers, revenue, clinical evidence — but feel like growth is harder than it should be. The first step is a strategy call where we assess fit and identify the highest-leverage opportunities.
